	Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. Breast Cancer (Dove Med Press) Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, Chen JH, Huang TC. PMID: 42261320 [PubMed]
	Beyond Target Occupancy in Triple-Negative Breast Cancer: A Medicinal Chemistry Perspective on Modality-Guided Design for Durable Network Control. J Med Chem Zeng W, Chen Y, Neamati N, Jin Y. PMID: 42261123 [PubMed - as supplied by publisher]
	Factors associated with the occurrence of breast nodules in perimenopausal women: A cross-sectional study in China. Medicine (Baltimore) Jiang X, Song L, Cai X, Zhang W, Meng L. PMID: 42260837 [PubMed - in process]
	Association of antihypertensive drugs, intestinal ischemia, and breast diseases: A drug-target Mendelian Randomization study. Medicine (Baltimore) Li J, Ma Y, Zhang K. PMID: 42260808 [PubMed - in process]
	Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancer. Exp Hematol Oncol Sahin TK, Orhan C, Ozercan IH, Muglu H, Er B, Akyildiz A, Tunbekici S, Oruc A, Aykan MB, Koylu B, Akdogan O, Onur ID, Ates O, Yazici O, Selcukbiricik F, Karadurmus N, Araz M, Erdem D, Goker E, Bilici A, Aksoy S, Guven DC. PMID: 42260640 [PubMed]
	Meta-analysis reveals pathological complete response benefits from neoadjuvant immuno-chemotherapy combination in patients with HER2-negative breast cancer. BMC Cancer Wei Y, Qi Y, Ge H, Zeng C, Li Q, Ma F. PMID: 42260448 [PubMed - as supplied by publisher]
	A PML1-CCL5-PI3K/MAPK feedback loop governs survival of endocrine-resistant breast cancer cells. Cell Death Differ Wang H, Yun Z, Cao Y, Li X, Liu Z, Pai CP, Wu C, Yue J, Lin G, Cai J, Fang S, Li K, Willard B, Yang S, Keri RA, Schiemann WP, Diehl JA, Kao HY. PMID: 42260104 [PubMed - as supplied by publisher]
	First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial. Nat Cancer Schmid P, Im SA, Nowecki Z, Wysocki PJ, Jassem J, Jung KH, Lord S, Armstrong J, Stewart R, Vukovi, Denduluri N, Park YH. PMID: 42259988 [PubMed - as supplied by publisher]
	Evaluating machine learning algorithms based on thermal imaging and milk-based parameters to identify subclinical mastitis in dairy cows. Vet Q Paudyal S, Neupane R, Shrestha B, Chiang HI, Aryal A. PMID: 42259761 [PubMed - in process]
	International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer. Eur J Surg Oncol Lucocq J, Karakatsanis A, Kirwan C, Boughey J, Tseng J, Sun SX, Gentilini OD, Barber M, Chagla L, Buccimazza I, Dick L, Massannat Y, Dixon JM, Kühn T, Benson J, Elder K, NAC-AX Collaborative Group. PMID: 42259722 [PubMed - as supplied by publisher]
	Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer. ESMO Open Salehi E, Chu X, Mayer EL, Singer S, Augdahl G, Stalteri M, Li T, Dibble KE, Sinclair N, Faggen M, Walsh J, Sammons S, Sendrick K, Hanna S, Mostaghimi A, Tayob N, LeBoeuf NR, Tolaney SM. PMID: 42258966 [PubMed - as supplied by publisher]
	Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies. J Clin Oncol Braunstein LZ, Mitchell MP, Khan AJ, Sikov WM, Mamounas EP, Julian TB, Wolmark N. PMID: 42258793 [PubMed - as supplied by publisher]
	The Development of Ultrasound Intervention in the Diagnosis and Treatment of Non-breast Superficial and Abdominal Diseases. J Vis Exp Du T, Leng WJSG, Wa Z. PMID: 42258485 [PubMed - in process]
	SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytes. Clin Transl Oncol Oses G, Clavell C, González-Farré B, Sanfeliu E, Laplana M, Martínez A, Moreno S, Meca G, Gomis E, Carreras-Ballvé J, Mension E, Cebrecos I, Caparrós X, Tarrats-Rosell J, Cases C, Herreros A, Mollà M. PMID: 42258139 [PubMed - as supplied by publisher]
	Withaferin A in breast cancer therapy: multi-targeted modulation of redox homeostasis, autophagy, and apoptosis. J Asian Nat Prod Res Patel N, Gupta A, Mishra R, Pandey SN, Goyal K, Ali H, Maji C, Rekha A, Hussain MS, Singh SK, Gupta G. PMID: 42257714 [PubMed - as supplied by publisher]
	Dynamic breast magnetic resonance imaging features and pathological correlation of patients diagnosed with breast cancer under the age of 40. Acta Radiol Gundogdu V, Meltem E, Ulusan MB, Bozkurt H, Mahmutoglu AS. PMID: 42257534 [PubMed - as supplied by publisher]
	Ipsilateral Breast Tumor Detected 20 Years after Occult Breast Cancer: A Diagnostic Challenge in Distinguishing New Primary Cancer from Late Recurrence. Case Rep Oncol Masuda Y, Tanaka M, Koga Y, Eto K, Watanabe R, Yoshinaga Y, Satou T. PMID: 42257037 [PubMed]
	Non-pharmacological sleep management in breast cancer survivors: Evidence from a systematic review and meta-analysis of RCTs. Prev Med Rep Aemmi SZ, Mohammadi-Pirouz Z, Moradi M. PMID: 42256805 [PubMed]
	Financial incentives for women's cervical, breast and colorectal cancer screening adherence: systematic review and meta-analysis. Prev Med Rep Lumia C, Nespoli A, Ausili D, Fumagalli S, Dumont A. PMID: 42256798 [PubMed]
	The Effect of a Program Based on the Common-Sense Model on Illness Perception and Health-Promoting Behaviors in Women with Breast Cancer: A Randomized Clinical Trial Study. Iran J Nurs Midwifery Res Bahrami M, Musarezaie A, Alidousti F. PMID: 42256750 [PubMed]

Articles 1 - 20 / 218550

Page 1 of 10928



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy